ESC Premium Access

Panel discussion; SGLT2 in clinical cardiology.

Topic: Primary cardiovascular prevention: interventions and outcomes
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Boehringer Ingelheim/Lilly

Congress Presentation

About the speakers

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)
167 presentations
8 followers

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
42 presentations
3 followers

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
51 presentations
3 followers

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)
18 presentations
0 follower

2 more presentations in this session

Introduction - Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure.

Speaker: Professor J. Deanfield (London, GB)

Thumbnail

SGLT2 inhibition in cardiology: what a cardiologist needs to know.

Speaker: Professor N. Sattar (Glasgow, GB)

Thumbnail

Access the full session

Modern management of diabetes in cardiology: impact of SGLT2 inhibition on cardiovascular outcomes and heart failure (EBAC Accredited)

Speakers: Professor S. Anker, Professor N. Sattar, Professor J. Deanfield, Doctor D. Fitchett, Professor J. Deanfield...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb